May 11, 2022 / 11:40AM GMT
Presentation (Q&A)
May 11, 2022 / 11:40AM GMT
=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Representative Director
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director
* Giles Platford
Takeda Pharmaceutical Company Limited - President of the PDT Business Unit
* Julie Kim
Takeda Pharmaceutical Company Limited - President of the U.S. Business Unit & U.S. Country Head
* Masato Iwasaki
Takeda Pharmaceutical Company Limited - Representative Director
* Ramona Sequeira
Takeda Pharmaceutical Company Limited - President of Global Portfolio Division
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
Takeda Pharmaceutical Co Ltd
(WBO:TKD)
€
29.91
+0.15 (+0.5%)
Market Cap: 47.49 Bil
Enterprise Value: 70.54 Bil
PE Ratio: 0
PB Ratio: 1.17
GF Score: 19/100 Full Year 2022 Takeda Pharmaceutical Co Ltd Earnings Presentation (Q&A) Transcript
May 11, 2022 / 11:40AM GMT
Release Date Price:
€27.07
(-1.20%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot